Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) EBIT Margin (2022 - 2024)

Moolec Science (MLECW) posted EBIT Margin of 77.92% for Q4 2024, up 42.26% sequentially from 134.97% in Q3 2024, and up 63328.0% YoY from N/an in Q1 2024.

Moolec Science (MLECW) EBIT Margin (2022 - 2024) Analysis & Trends

Moolec Science has reported EBIT Margin for 3 years, with the latest figure at 77.92% in Q4 2024.

  • Quarterly EBIT Margin rose 63328.0% year-over-year to 77.92% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 116.72% (down 14997.0% YoY) and the FY2024 annual result came in at 160.76%, up 57443.0% from the prior year.
  • EBIT Margin grew to 77.92% in Q4 2024 per MLECW's latest filing, from 134.97% in the prior quarter.
  • Over five years, EBIT Margin peaked at 6246.22% in Q3 2022 and troughed at 63974.35% in Q2 2022.
  • A 3-year average of 3939.29% and a median of 87.35% in 2024 frame the typical range for EBIT Margin.
  • The widest YoY moves for EBIT Margin: up 6398769 bps in 2023, down 637655 bps in 2023.
  • Over 3 years, EBIT Margin stood at 4943.14% in 2022, then tumbled by 114 bps to 711.2% in 2023, then jumped by 89 bps to 77.92% in 2024.
  • According to Business Quant data, EBIT Margin over the past three periods registered 77.92%, 134.97%, and 193.03% for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 30.15%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 32.54%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -562.07%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 19.06%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 17.93%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -35.57%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.36%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.75%
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -77.92%
Sep 30, 2024 -134.97%
Jun 30, 2024 -193.03%
Mar 31, 2024 -96.78%
Dec 31, 2023 -711.20%
Sep 30, 2023 -130.34%
Jun 30, 2023 13.34%
Mar 31, 2023 4,893.20%
Dec 31, 2022 4,943.14%
Sep 30, 2022 6,246.22%
Jun 30, 2022 -63,974.35%
Mar 31, 2022 1,951.15%